Mingzhu Yin

Mingzhu Yin received the Ph.D. degree in integration traditional Chinese and Western medicine from China Pharmaceutical University, in 2018. He completed the first postdoctoral training on genetics from the National Institute on Aging, National Institutes of Health, in 2011, and the second postdoctoral training on pathology from Yale University, in 2013. He is a Professor and the Chair of the Cancer Early Diagnosis Center (CEDC), the Clinical Research Center (CRC), and the Clinical Pathology Center (CPC), Chongqing University Three Gorges Hospital, Chongqing University; the Director of the Translational Medicine Research Center (TMRC), Chongqing University; and an Adjunct Assistant Professor with the Department of Pathology, Yale University School of Medicine. After returning to China in 2018, he has established the largest domestic single-cell sequencing and analysis technology platform and database. He was approved as the Top Young Talents of Ten Thousand Talents Program of Organization Department, Central Committee, CPC, in 2019; the Hunan Outstanding Youth Fund, in 2021; and the Leading Talent of the Ministry of Industry and Information Technology, in 2022.